Recursion Pharmaceuticals bets on REC-4881, cancer candidates and new hypophosphatasia therapy to rebuild momentum after key drug cuts rattled investors.

A research team from the University of Manitoba has discovered a new genus of placoderm fish, named Elmosteus lundarensis, ...